It was a year that saw the introduction of the new $4 billion Medicare Drug Rebate program, and that helped lift more than 3 million people from the ranks of the uninsured.
That meant more than 12 million Americans were covered by Medicare for the first time, and the overall national health care system had more than quadrupled its spending under the Affordable Care Act, according to a new report from the Kaiser Family Foundation.
The numbers also showed that the cost of prescription drugs went down in 2017.
The median price of a new drug approved by the Food and Drug Administration (FDA) last year was $10,500, up from $8,000 in 2017, according the report.
But the number of prescriptions issued in 2017 fell 3.7% to nearly 4.2 million, according a Kaiser report, and overall prescription spending rose 8.3%.
Overall, prescription spending fell 3% from $3.3 trillion in 2017 to $3 trillion, but the number filling those prescriptions grew more than 8%.
This suggests that the new program will be able to pay for itself and make the US health care industry more efficient.
The program is aimed at paying doctors more money for treating the uninsured and providing care to people with chronic illnesses and conditions.
The money is intended to offset the rising costs of prescription medications.